These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1494403)

  • 1. A newly discovered function of the erythrocyte: transport of immune complexes to the liver.
    Halma C; van Es LA; Daha MR
    Neth J Med; 1992 Dec; 41(5-6):245-54. PubMed ID: 1494403
    [No Abstract]   [Full Text] [Related]  

  • 2. Biologic significance of the erythrocyte complement receptor: a primate perquisite.
    Hebert LA; Cosio FG; Birmingham DJ; Mahan JD
    J Lab Clin Med; 1991 Oct; 118(4):301-8. PubMed ID: 1940571
    [No Abstract]   [Full Text] [Related]  

  • 3. Erythrocyte complement receptor type 1 in patients with systemic lupus erythematosus.
    Yen JH; Liu HW; Lin SF; Chen JR; Chen TP
    J Rheumatol; 1989 Oct; 16(10):1320-5. PubMed ID: 2810256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement and its receptor: a physiological transport system for circulating immune complexes.
    Schifferli JA; Paccaud JP
    Contrib Nephrol; 1989; 69():1-8; discussion 37-8. PubMed ID: 2525454
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantification of the complement receptor function on polymorphonuclear leukocytes: its significance in patients with systemic lupus erythematosus.
    Yoshida K; Yukiyama Y; Miyamoto T
    J Rheumatol; 1987 Jun; 14(3):490-6. PubMed ID: 3498035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Elimination of immune complexes: role of complement].
    Schifferli JA
    Schweiz Med Wochenschr; 1985 Oct; 115(41):1422-4. PubMed ID: 2933806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of factor B in residual immune complex red cell binding activity observed in serum from a C2-deficient systemic lupus erythematosus patient may delay the appearance of clinical symptoms.
    Traustadóttir KH; Rafnar BO; Steinsson K; Valdimarsson H; Erlendsson K
    Arthritis Rheum; 1998 Mar; 41(3):427-34. PubMed ID: 9506570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biology of immune complexes and their possible role in pregnancy.
    Theofilopoulos AN; Gleicher N; Pereira AB; Dixon FJ
    Prog Clin Biol Res; 1981; 70():93-114. PubMed ID: 7031704
    [No Abstract]   [Full Text] [Related]  

  • 9. Tetanus toxoid-anti-tetanus toxoid complexes: a potential model to study the complement transport system for immune complex in humans.
    Paccaud JP; Steiger G; Sjöholm AG; Spaeth PJ; Schifferli JA
    Clin Exp Immunol; 1987 Aug; 69(2):468-76. PubMed ID: 2958199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the relationship between complement and systemic lupus erythematosus?
    Podrebarac TA; Goldstein R
    J Rheumatol; 1998 Nov; 25(11):2062-4. PubMed ID: 9818645
    [No Abstract]   [Full Text] [Related]  

  • 11. A lysine-binding protein in SLE sera inhibits the binding of immune complexes to normal erythrocyte CR1 (complement receptor type 1).
    Ng YC; Peters DK; Cederholm-Williams SA; Walport MJ
    Clin Exp Immunol; 1987 Jul; 69(1):89-97. PubMed ID: 3115654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms.
    Schifferli JA; Ng YC; Estreicher J; Walport MJ
    J Immunol; 1988 Feb; 140(3):899-904. PubMed ID: 2963069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes.
    Nielsen CH; Rasmussen JM; Voss A; Junker P; Leslie RG
    Arthritis Rheum; 1998 Apr; 41(4):613-22. PubMed ID: 9550470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on immune adherence (C3b) receptor activity of human erythrocytes: relationship between receptor activity and presence of immune complexes in serum.
    Inada Y; Kamiyama M; Kanemitsu T; Hyman CL; Clark WS
    Clin Exp Immunol; 1982 Oct; 50(1):189-97. PubMed ID: 6216998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement fixing immune complexes containing antinuclear antibodies in patients with systemic lupus erythematosus.
    Budd JJ; Moore TL; Osborn TG
    J Rheumatol; 1988 Feb; 15(2):247-50. PubMed ID: 3258914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cells.
    Emlen W; Burdick G; Carl V; Lachmann PJ
    J Immunol; 1989 Jun; 142(12):4366-71. PubMed ID: 2524529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The complement-mediated binding of soluble antibody/dsDNA immune complexes to human neutrophils.
    Taylor RP; Burge J; Horgan C; Shasby DM
    J Immunol; 1983 Jun; 130(6):2656-62. PubMed ID: 6854016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation].
    Pascual M; Schifferli JA
    Schweiz Med Wochenschr; 1993 Jan; 123(3):39-43. PubMed ID: 8426946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study of complement receptor abnormalities].
    Aikawa T
    Nihon Rinsho; 1988 Sep; 46(9):2035-9. PubMed ID: 3241393
    [No Abstract]   [Full Text] [Related]  

  • 20. C4AQ0 superimposed on a primary defect increases the susceptibility to systemic lupus erythematosus (SLE) in a family with association between C4AQ0 and SLE.
    Traustadóttir KH; Steinsson K; Erlendsson K
    J Rheumatol; 1998 Nov; 25(11):2118-25. PubMed ID: 9818652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.